1μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
| Species | Human |
| Synonyms | CD171,L1CAM |
| Accession | P32004 |
| Amino Acid Sequence | Ile20-Glu1120, with C-terminal His |
| Expression System | HEK293 |
| Molecular Weight | 150-180kDa (Reducing) |
| Purity | >95% by SDS-PAGE |
| Endotoxin | <0.1EU/μg |
| Conjugation | Unconjugated |
| Tag | His Tag |
| Physical Appearance | Lyophilized Powder |
| Storage Buffer | PBS, pH7.4. |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
| Reference | 1.Review Cell Adh Migr.2012 Jul-Aug;6(4):374-84. Epub 2012 Jul 1. |
Background
L1 cell adhesion molecule (L1CAM), also known as CD171, is a cell adhesion receptor in the immunoglobulin superfamily, which plays an important role in the development of the nervous system. L1CAM interacts with a variety of ligands. Including axon protein 1, CD9, neurocan, and integrins. The molecule is a type I transmembrane (TM) protein that contains an 1101 aa extracellular region (aa 20-1120) plus a 114 aa cytoplasmic domain (aa 1144-1257). Recent work has identified L1CAM (CD171) as a novel marker for human carcinoma progression, and a candidate for anti-cancer therapy.
Picture
Picture
SDS-PAGE
